These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 15072706)

  • 1. Methimazole-induced aplastic anemia caused by hypocellular bone marrow with plasmacytosis.
    Yamamoto A; Katayama Y; Tomiyama K; Hosoai H; Hirata F; Kimura F; Fujita K; Yasuda H
    Thyroid; 2004 Mar; 14(3):231-5. PubMed ID: 15072706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Massive plasmocytosis due to methimazole-induced bone marrow toxicity.
    Breier DV; Rendo P; Gonzalez J; Shilton G; Stivel M; Goldztein S
    Am J Hematol; 2001 Aug; 67(4):259-61. PubMed ID: 11443640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methimazole-induced aplastic anemia in third exposure: successful treatment with recombinant human granulocyte colony-stimulating factor.
    Mezquita P; Luna V; Muñoz-Torres M; Torres-Vela E; Lopez-Rodriguez F; Callejas JL; Escobar-Jimenez F
    Thyroid; 1998 Sep; 8(9):791-4. PubMed ID: 9777751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methimazole-induced severe aplastic anemia: unsuccessful treatment with recombinant human granulocyte-monocyte colony-stimulating factor.
    Escobar-Morreale HF; Bravo P; García-Robles R; García-Laraña J; de la Calle H; Sancho JM
    Thyroid; 1997 Feb; 7(1):67-70. PubMed ID: 9086574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Severe aplastic anemia as a complication of treatment with metizol].
    Swider G; Grzywa M; Zuzak Z
    Wiad Lek; 1996; 49(7-12):136-9. PubMed ID: 9245107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient methimazole-induced bone marrow aplasia: in vitro evidence for a humoral mechanism of bone marrow suppression.
    Moreb J; Shemesh O; Shilo S; Manor C; Hershko C
    Acta Haematol; 1983; 69(2):127-31. PubMed ID: 6188311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methimazole-induced agranulocytosis in patients with Graves' disease is more frequent with an initial dose of 30 mg daily than with 15 mg daily.
    Takata K; Kubota S; Fukata S; Kudo T; Nishihara E; Ito M; Amino N; Miyauchi A
    Thyroid; 2009 Jun; 19(6):559-63. PubMed ID: 19445623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of efficacy and adverse effects between methimazole 15 mg+inorganic iodine 38 mg/day and methimazole 30 mg/day as initial therapy for Graves' disease patients with moderate to severe hyperthyroidism.
    Sato S; Noh JY; Sato S; Suzuki M; Yasuda S; Matsumoto M; Kunii Y; Mukasa K; Sugino K; Ito K; Nagataki S; Taniyama M
    Thyroid; 2015 Jan; 25(1):43-50. PubMed ID: 25178068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics of antithyroid drug-induced aplastic anemia cases over the past 30 years.
    Cheng Y; Xia XY; Zhang W; Ren L; Tian CF; Liu D; Xue G
    Front Endocrinol (Lausanne); 2023; 14():1064723. PubMed ID: 36777352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute pancreatitis induced by methimazole in a patient with Graves' disease.
    Yang M; Qu H; Deng HC
    Thyroid; 2012 Jan; 22(1):94-6. PubMed ID: 22136208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithyroid drug-induced aplastic anemia.
    Thomas D; Moisidis A; Tsiakalos A; Alexandraki K; Syriou V; Kaltsas G
    Thyroid; 2008 Oct; 18(10):1043-8. PubMed ID: 18816182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bone marrow aplasia and liver damage caused by methimazole].
    Undas A; Dreger B; Skałuba Z; Musiał J
    Pol Arch Med Wewn; 1998 Jun; 99(6):493-6. PubMed ID: 10085704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of antihistamines after serious allergic reaction to methimazole in pediatric Graves' disease.
    Toderian AB; Lawson ML
    Pediatrics; 2014 May; 133(5):e1401-4. PubMed ID: 24777217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remission of aplastic anemia induced by treatment for Graves disease in a pediatric patient.
    Das PK; Wherrett D; Dror Y
    Pediatr Blood Cancer; 2007 Aug; 49(2):210-2. PubMed ID: 16456859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute pancreatitis and parotitis induced by methimazole in a patient with Graves' disease.
    Taguchi M; Yokota M; Koyano H; Endo Y; Ozawa Y
    Clin Endocrinol (Oxf); 1999 Nov; 51(5):667-70. PubMed ID: 10594530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of methimazole-induced severe aplastic anaemia in a diabetic patient with other co-morbidities.
    Josol CV; Buenaluz-Sedurante M; Sandoval MA; Castillo G
    BMJ Case Rep; 2010 Dec; 2010():. PubMed ID: 22802368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morning granulocytopenia in a case of Graves' disease.
    Nakamura S; Isaji M; Ishimori M
    Endocr J; 2001 Apr; 48(2):181-4. PubMed ID: 11456265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
    He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Agranulocytosis, plasmacytosis, and thrombocytosis due to methimazole-induced bone marrow toxicity.
    Oh EJ; Chae HJ; Park YJ; Park JW; Han K
    Am J Hematol; 2007 Jun; 82(6):500. PubMed ID: 17266051
    [No Abstract]   [Full Text] [Related]  

  • 20. [Fever due to antithyroid agents].
    Shamelian SO; Nortier JW
    Ned Tijdschr Geneeskd; 1999 Jan; 143(5):225-8. PubMed ID: 10086149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.